![](../images/trans.gif) |
![](../images/trans.gif) |
|
![](../images/trans.gif) |
![](../images/trans.gif) |
|
![](../images/trans.gif) |
![](../images/trans.gif) |
|
![](../images/trans.gif) |
![](../images/spacer.gif) |
Back To News:
RiconPharma is actively seeking partners for the development of NDA Products using 505 (b) (2) regulatory pathway.
|
![](../images/spacer.gif) |
RiconPharma is actively seeking partners for the development of NDA Products using 505 (b) (2) regulatory pathway.
[July 10, 2009]
|
![](../images/spacer.gif) |
RiconPharma is actively seeking partners for the development of NDA Products using 505 (b) (2) regulatory pathway.
|
|
|
|
|
|
|
![](../images/trans.gif) |
|
|
![](../images/trans.gif) |
© 2024 RiconPharma LLC. All Rights Reserved.
|
Powered By:
|
|
|
![](../images/trans.gif) |
|